Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bloom Psychedelic Therapy and Research Centre
Calgary, Alberta, Canada
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Bloom is/was conducting a Phase 1 dosing study with psilocybin, aiming to identify optimal micro/low doses for general well-being. The centre also partnered on clinical trials for psychedelic-assisted therapies including ketamine.[5][2][4]
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- Small moleculeNon-pharmacological therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
Optimi HealthIMPACT Clinical Trial Accelerator Program (University of Calgary)
Beyond the preview
Go deeper on Bloom Psychedelic Therapy and Research Centre.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bloom Psychedelic Therapy and Research Centre.